(Hypertension. 1995;25:201-206.)
© 1995 American Heart Association, Inc.
Articles |
From the Research Institute of Angiocardiology and Cardiovascular Clinic, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Correspondence to Kensuke Egashira, MD, PhD, Research Institute of Angiocardiology, Kyushu University School of Medicine, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812, Japan.
Abstract Hypertensive patients have impaired endothelium-dependent coronary vasodilation evoked with acetylcholine. The aim of this study was to examine whether the impaired endothelium-dependent dilation of coronary arteries is related to a specific abnormality of the muscarinic receptor that mediates the effects of acetylcholine. Responses of the large epicardial and resistance coronary arteries were assessed in seven hypertensive patients (mean arterial pressure, 106±14 mm Hg) and seven control subjects (83±6 mm Hg, P<.01) during cardiac catheterization. To assess coronary endothelial function, we infused acetylcholine and substance P (endothelium-dependent agents that act on different receptors) and papaverine and nitrate (direct vascular smooth muscle dilators) into the left anterior descending coronary artery and determined coronary artery diameter by arteriography and coronary blood flow with an intracoronary Doppler catheter technique. In control subjects, 3 µg/min acetylcholine increased (P<.05) and 30 µg/min acetylcholine decreased (P<.05) arterial diameter, and in hypertensive patients, 1, 3, 10, and 30 µg/min acetylcholine decreased arterial diameter in a dose-dependent manner. Substance P at 3, 10, and 30 ng/min caused comparable increases in diameter in both groups. Increases in coronary blood flow with both acetylcholine and substance P were significantly (P<.01) blunted in hypertensive patients compared with control subjects. No significant differences were noted between the groups in the responses of large epicardial coronary artery diameter and coronary blood flow to papaverine and nitrate. Vasodilation of the large coronary artery with acetylcholine was impaired, but the response to substance P was preserved in hypertensive patients, indicating that diminished vasodilation of the large epicardial coronary artery in hypertensive patients may be related to a specific abnormality in the endothelial muscarinic receptor. Blunted coronary blood flow responses to both acetylcholine and substance P in hypertensive patients suggest that endothelial dysfunction in the resistance coronary artery in this condition is related to a more generalized endothelial abnormality but is not confined to the muscarinic receptor.
Key Words: vasodilation hypertension, essential coronary circulation acetylcholine substance P endothelium-derived relaxing factor
This article has been cited by other articles:
![]() |
C. L. McGowan, A. S. Levy, P. J. Millar, J. C. Guzman, C. A. Morillo, N. McCartney, and M. J. MacDonald Acute vascular responses to isometric handgrip exercise and effects of training in persons medicated for hypertension Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1797 - H1802. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J Green, A. Maiorana, G. O'Driscoll, and R. Taylor Effect of exercise training on endothelium-derived nitric oxide function in humans J. Physiol., November 15, 2004; 561(1): 1 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. F. Galley and N. R. Webster Physiology of the endothelium Br. J. Anaesth., July 1, 2004; 93(1): 105 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Inokuchi, Y. Hirooka, H. Shimokawa, K. Sakai, T. Kishi, K. Ito, Y. Kimura, and A. Takeshita Role of Endothelium-Derived Hyperpolarizing Factor in Human Forearm Circulation Hypertension, November 1, 2003; 42(5): 919 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Schindler, E. U. Nitzsche, T. Munzel, M. Olschewski, I. Brink, M. Jeserich, M. Mix, P. T. Buser, M. Pfisterer, U. Solzbach, et al. Coronary vasoregulation in patients with various risk factors in response to cold pressor testing: Contrasting myocardial blood flow responses to short- and long-term vitamin C administration J. Am. Coll. Cardiol., September 3, 2003; 42(5): 814 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Higashi, S. Sasaki, K. Nakagawa, M. Kimura, S. Sasaki, K. Noma, H. Matsuura, K. Hara, C. Goto, T. Oshima, et al. Excess Norepinephrine Impairs Both Endothelium-Dependent and -Independent Vasodilation in Patients With Pheochromocytoma Hypertension, February 1, 2002; 39(2): 513 - 518. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Pullin, P. A. L. Ashfield-Watt, M. L. Burr, Z. E. Clark, M. J. Lewis, S. J. Moat, R. G. Newcombe, H. J. Powers, J. M. Whiting, and I. F. W. McDowell Optimization of dietary folate or low-dose folic acid supplements lower homocysteine but do not enhance endothelial function in healthy adults, irrespective of the methylenetetrahydrofolate reductase (C677T) genotype J. Am. Coll. Cardiol., December 1, 2001; 38(7): 1799 - 1805. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.P. Pellegrini, D. E Newby, S. Maxwell, and D. J Webb Short-term effects of transdermal nicotine on acute tissue plasminogen activator release in vivo in man Cardiovasc Res, November 1, 2001; 52(2): 321 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sasaki, Y. Higashi, K. Nakagawa, H. Matsuura, G. Kajiyama, and T. Oshima Effects of Angiotensin-(1-7) on Forearm Circulation in Normotensive Subjects and Patients With Essential Hypertension Hypertension, July 1, 2001; 38(1): 90 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Higashi, S. Sasaki, K. Nakagawa, H. Matsuura, G. Kajiyama, and T. Oshima Effect of the angiotensin-converting enzyme inhibitor imidapril on reactive hyperemia in patients with essential hypertension: relationship between treatment periods and resistance artery endothelial function J. Am. Coll. Cardiol., March 1, 2001; 37(3): 863 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Gauthier and N. J. Rusch Rat Coronary Endothelial Cell Membrane Potential Responses During Hypertension Hypertension, January 1, 2001; 37(1): 66 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Nickenig, A. Stablein, S. Wassmann, C. Wyen, C. Muller, and M. Bohm Acute effects of ACE inhibition on coronary endothelial dysfunction Journal of Renin-Angiotensin-Aldosterone System, December 1, 2000; 1(4): 361 - 364. [Abstract] [PDF] |
||||
![]() |
J. E. Graves, I. A. Greenwood, and W. A. Large Tonic regulation of vascular tone by nitric oxide and chloride ions in rat isolated small coronary arteries Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2604 - H2611. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.Y.H Lip, D.C Felmeden, F.L Li-Saw-Hee, and D.G Beevers Hypertensive heart disease. A complex syndrome or a hypertensive 'cardiomyopathy'? Eur. Heart J., October 2, 2000; 21(20): 1653 - 1665. [PDF] |
||||
![]() |
J. A. Vita, A. C. Yeung, M. Winniford, J. M. Hodgson, C. B. Treasure, J. L. Klein, S. Werns, M. Kern, D. Plotkin, W. J. Shih, et al. Effect of Cholesterol-Lowering Therapy on Coronary Endothelial Vasomotor Function in Patients With Coronary Artery Disease Circulation, August 22, 2000; 102(8): 846 - 851. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. G. Stroes, E. E. van Faassen, M. Yo, P. Martasek, P. Boer, R. Govers, and T. J. Rabelink Folic Acid Reverts Dysfunction of Endothelial Nitric Oxide Synthase Circ. Res., June 9, 2000; 86(11): 1129 - 1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Laine, P. Nuutila, M. Luotolahti, C. Meyer, T. Elomaa, P. Koskinen, T. Rönnemaa, and J. Knuuti Insulin-Induced Increment of Coronary Flow Reserve Is Not Abolished by Dexamethasone in Healthy Young Men J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1868 - 1873. [Abstract] [Full Text] |
||||
![]() |
Y. Zhang and D. B. Hoover Signaling Mechanisms for Muscarinic Receptor-Mediated Coronary Vasoconstriction in Isolated Rat Hearts J. Pharmacol. Exp. Ther., April 1, 2000; 293(1): 96 - 106. [Abstract] [Full Text] |
||||
![]() |
Y. Higashi, S. Sasaki, K. Nakagawa, T. Ueda, A. Yoshimizu, S. Kurisu, H. Matsuura, G. Kajiyama, and T. Oshima A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study J. Am. Coll. Cardiol., February 1, 2000; 35(2): 284 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
E G Zouridakis, I D Cox, X Garcia-Moll, S Brown, P Nihoyannopoulos, and J C Kaski Negative stress echocardiographic responses in normotensive and hypertensive patients with angina pectoris, positive exercise stress testing, and normal coronary arteriograms Heart, February 1, 2000; 83(2): 141 - 146. [Abstract] [Full Text] |
||||
![]() |
M. Usui, K. Egashira, H. Tomita, M. Koyanagi, M. Katoh, H. Shimokawa, M. Takeya, T. Yoshimura, K. Matsushima, and A. Takeshita Important Role of Local Angiotensin II Activity Mediated via Type 1 Receptor in the Pathogenesis of Cardiovascular Inflammatory Changes Induced by Chronic Blockade of Nitric Oxide Synthesis in Rats Circulation, January 25, 2000; 101(3): 305 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Koyanagi, K. Egashira, M. Kubo-Inoue, M. Usui, S. Kitamoto, H. Tomita, H. Shimokawa, and A. Takeshita Role of Transforming Growth Factor-{beta}1 in Cardiovascular Inflammatory Changes Induced by Chronic Inhibition of Nitric Oxide Synthesis Hypertension, January 1, 2000; 35(1): 86 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Usui, K. Egashira, S. Kitamoto, M. Koyanagi, M. Katoh, C. Kataoka, H. Shimokawa, and A. Takeshita Pathogenic Role of Oxidative Stress in Vascular Angiotensin-Converting Enzyme Activation in Long-Term Blockade of Nitric Oxide Synthesis in Rats Hypertension, October 1, 1999; 34(4): 546 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Higashi, S. Sasaki, S. Kurisu, A. Yoshimizu, N. Sasaki, H. Matsuura, G. Kajiyama, and T. Oshima Regular Aerobic Exercise Augments Endothelium-Dependent Vascular Relaxation in Normotensive As Well As Hypertensive Subjects : Role of Endothelium-Derived Nitric Oxide Circulation, September 14, 1999; 100(11): 1194 - 1202. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Thalhammer, B. Balzuweit, A. Busjahn, C. Walter, F. C. Luft, and H. Haller Endothelial Cell Dysfunction and Arterial Wall Hypertrophy Are Associated With Disturbed Carbohydrate Metabolism in Patients at Risk for Cardiovascular Disease Arterioscler Thromb Vasc Biol, May 1, 1999; 19(5): 1173 - 1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Higashi, S. Sasaki, N. Sasaki, K. Nakagawa, T. Ueda, A. Yoshimizu, S. Kurisu, H. Matsuura, G. Kajiyama, and T. Oshima Daily Aerobic Exercise Improves Reactive Hyperemia in Patients With Essential Hypertension Hypertension, January 1, 1999; 33(1): 591 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Katoh, K. Egashira, M. Usui, T. Ichiki, H. Tomita, H. Shimokawa, H. Rakugi, and A. Takeshita Cardiac Angiotensin II Receptors Are Upregulated by Long-Term Inhibition of Nitric Oxide Synthesis in Rats Circ. Res., October 5, 1998; 83(7): 743 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tomita, K. Egashira, Y. Ohara, M. Takemoto, M. Koyanagi, M. Katoh, H. Yamamoto, K. Tamaki, H. Shimokawa, and A. Takeshita Early Induction of Transforming Growth Factor-ß via Angiotensin II Type 1 Receptors Contributes to Cardiac Fibrosis Induced by Long-term Blockade of Nitric Oxide Synthesis in Rats Hypertension, August 1, 1998; 32(2): 273 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Laine, O. T. Raitakari, H. Niinikoski, O.-P. Pitkanen, H. Iida, J. Viikari, P. Nuutila, and J. Knuuti Early impairment of coronary flow reserve in young men with borderline hypertension J. Am. Coll. Cardiol., July 1, 1998; 32(1): 147 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. McGill Jr, C. A. McMahan, R. E. Tracy, M. C. Oalmann, J. F. Cornhill, E. E. Herderick, and J. P. Strong Relation of a Postmortem Renal Index of Hypertension to Atherosclerosis and Coronary Artery Size in Young Men and Women Arterioscler Thromb Vasc Biol, July 1, 1998; 18(7): 1108 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Higashi, T. Oshima, S. Sasaki, Y. Nakano, M. Kambe, H. Matsuura, and G. Kajiyama Angiotensin-Converting Enzyme Inhibition, But Not Calcium Antagonism, Improves a Response of the Renal Vasculature to L-Arginine in Patients With Essential Hypertension Hypertension, July 1, 1998; 32(1): 16 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cardillo and J. A Panza Impaired endothelial regulation of vascular tone in patients with systemic arterial hypertension Vascular Medicine, May 1, 1998; 3(2): 138 - 144. [Abstract] [PDF] |
||||
![]() |
U. C. Kopp, M. Z. Cicha, D. M. Farley, L. A. Smith, and B. S. Dixon Renal Substance P–Containing Neurons and Substance P Receptors Impaired in Hypertension Hypertension, March 1, 1998; 31(3): 815 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ghaleh, L. Hittinger, S.-J. Kim, R. K. Kudej, M. Iwase, M. Uechi, A. Berdeaux, S. P. Bishop, and S. F. Vatner Selective large coronary endothelial dysfunction in conscious dogs with chronic coronary pressure overload Am J Physiol Heart Circ Physiol, February 1, 1998; 274(2): H539 - H551. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Gauthier-Rein and N. J. Rusch Distinct Endothelial Impairment in Coronary Microvessels from Hypertensive Dahl Rats Hypertension, January 1, 1998; 31(1): 328 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Takemoto, K. Egashira, H. Tomita, M. Usui, H. Okamoto, A. Kitabatake, H. Shimokawa, K. Sueishi, and A. Takeshita Chronic Angiotensin-Converting Enzyme Inhibition and Angiotensin II Type 1 Receptor Blockade : Effects on Cardiovascular Remodeling in Rats Induced by the Long-term Blockade of Nitric Oxide Synthesis Hypertension, December 1, 1997; 30(6): 1621 - 1627. [Abstract] [Full Text] |
||||
![]() |
U. Solzbach, B. Hornig, M. Jeserich, and H. Just Vitamin C Improves Endothelial Dysfunction of Epicardial Coronary Arteries in Hypertensive Patients Circulation, September 2, 1997; 96(5): 1513 - 1519. [Abstract] [Full Text] |
||||
![]() |
D. B. Hoover and D. A. Neely Differentiation of Muscarinic Receptors Mediating Negative Chronotropic and Vasoconstrictor Responses to Acetylcholine in Isolated Rat Hearts J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1337 - 1344. [Abstract] [Full Text] |
||||
![]() |
A. A. Quyyumi, D. Mulcahy, N. P. Andrews, S. Husain, J. A. Panza, and R. O. Cannon III Coronary Vascular Nitric Oxide Activity in Hypertension and Hypercholesterolemia: Comparison of Acetylcholine and Substance P Circulation, January 7, 1997; 95(1): 104 - 110. [Abstract] [Full Text] |
||||
![]() |
K. Numaguchi, K. Egashira, M. Takemoto, T. Kadokami, H. Shimokawa, K. Sueishi, and A. Takeshita Chronic Inhibition of Nitric Oxide Synthesis Causes Coronary Microvascular Remodeling in Rats Hypertension, December 1, 1995; 26(6): 957 - 962. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |